Singularly, FLT-TKD mutations do not confer decreased survival in patients with AML; however, there are trends to decreased overall survival in patients with a co-occurring FLT3-ITD or a co-occurring MLL-partial tandem duplication mutations, as demonstrated by Bacher et al. [13]. Here, FLT3 is linked to acute myeloid leukemia.